Company Information
USD
6.75
- (-5.3%)
NASDAQ:TCRX, TSCAN THERAPEUTICS, INC.
Industry: Biotechnology
End of Day: 17 April 2024 GMT-4
TScan Therapeutics Inc is a biopharmaceutical company focused on the development of T-cell receptor (TCR) engineered T cell therapies (TCR-T) for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.
Address
830 Winter Street
Website
Classification
Sector
Healthcare
Industry Group
Biotechnology
Industry
Biotechnology
Key Executives
Mr. Jason A. Amello
CFO/Chief Accounting Officer/Treasurer
Dr. Gavin MacBeath, PhD
CEO/Director
Mr. Leiden Dworak
Vice President, Divisional
Mr. Timothy J. Barberich
Chairman of the Board/Director
Dr. Stephen R. Biggar,M.D.,PhD
Director
Ms. Katina Dorton, J.D.,M.B.A.
Director
Dr. Barbara Klencke, M.D.
Director
Mr. Robert Keith Woods
Director
Dr. Gabriela Gruia, M.D.
Director
Dr. Shrikanta Chattopadhyay, M.D.
Senior VP, Divisional
Ms. Ann Hargraves
Senior VP, Divisional
Mr. Ray Lockard, M.B.A.
Senior VP, Divisional
Dr. Zoran Zdraveski
Chief Legal Officer/Secretary
Dr. Debora Barton, M.D.
Chief Medical Officer
Ownership
Institution Holdings
EcoR1 Capital, LLC
5,000,000 (10.455%)
K2 HealthVentures Equity Trust LLC
4,588,034 (9.593%)
Adage Capital Partners Gp LLC
3,900,000 (8.155%)
Bvf Inc
2,989,474 (6.251%)
Baker Bros Advisors LP
2,784,792 (5.823%)
Baker Bros. Advisors LP
2,784,792 (5.823%)
Vanguard Group Inc
1,788,152 (3.739%)
BlackRock Inc
1,671,727 (3.496%)
Alphabet Inc
1,077,080 (2.252%)
Simplify Asset Management Inc.
1,046,916 (2.189%)
Individual Holdings
Mr. David P. Southwell
171,569 (0.908%)
Mr. Gavin MacBeath
49,767 (0.264%)
Mr. Timothy J. Barberich
67,027 (0.154%)
Dr. Barbara Klencke, M.D.
30,000 (0.069%)
Dr. Zoran Zdraveski
4,716 (0.025%)
Mr. Leiden Dworak
5,692 (0.013%)
Funds Holdings
Vanguard Institutional Extnd Mkt Idx Tr
537,793 (1.125%)
Fidelity Extended Market Index Fund
216,566 (0.453%)
BlackRock Extended Equity Market
90,085 (0.188%)
NT Ext Equity Market Index Fund - L
35,157 (0.074%)
NT DJ US Complt Ttl Stk Mkt Idx Eq Strat
35,157 (0.074%)
NT Ext Equity Mkt Idx Fd - DC - NL
26,682 (0.056%)
Spartan Total Market Index Pool
23,436 (0.049%)
Spartan Extended Market Index Pool
13,267 (0.028%)
Extended Equity Market Fund M
11,139 (0.023%)
Nationwide Multi-Cap Portfolio
6,725 (0.014%)
Make Smart Investment Choices
8BIT Global Pte Ltd.
1557 Keppel Road, #01-01
Singapore 089066
Singapore 089066
